FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

St. Jude Replaces Silicone ICD Leads with Optim Leads

[ Price : $8.95]

St. Jude Medical says it is phasing out its Riata and Riata ST family of defibrillation leads which use silicone as the outer insu...

FDA Seeking End to Avastin Breast Cancer Indication

[ Price : $8.95]

Under immediate House Republican denunciation, FDA recommends that the Avastin breast cancer indication be removed from labeling a...

Advisors Suggest a Partial Ban on Dental Amalgam

[ Price : $8.95]

Members of CDRHs dental advisory panel exceeding their mandate suggest banning use of dental amalgam in children.

New Blood Collection System Cleared

[ Price : $8.95]

FDA clears a Fenwal 510(k) for its Alyx component collection system that is designed with new wireless data export capabilities.

Review Period Set for Angiomax

[ Price : $8.95]

Federal Register Notice: FDA determines the regulatory review period for The Medicines Companys Angiomax for the purpose of patent...

Small Entity Compliance Guide for Supplements

[ Price : $8.95]

Federal Register Notice: FDA releases a small entity compliance guide on CGMPs in manufacturing, packaging, labeling or holding op...

FDA OKs Neuralstem IND for Anti-depressant

[ Price : $8.95]

FDA approves a Neuralstem, Inc. IND to begin a Phase 1a safety trial of NSI-189 in major depression.

Pros and Cons of Mercury Amalgam Presented to FDA Panel

[ Price : $8.95]

FDAs Medical Devices Advisory Committee hears a wide variety of views regarding the safety and classification of dental amalgam.

Safety Board Discusses Methemoglobinemia, Benzocaine

[ Price : $8.95]

CDERs Drug Safety Oversight Board says it discussed a concern involving benzocaine and methemglobinemia at its 11/18 meeting.

Adventrx Wants FDA Meeting on ANX-514 Study

[ Price : $8.95]

Adventrx Pharmaceuticals says it is seeking a meeting with FDA to discuss results of a bioquivalence study of its drug candidate A...